Company Filing History:
Years Active: 1989-1990
Title: The Innovations of Mario Ercole Scevola
Introduction
Mario Ercole Scevola is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of arthrosis diseases. With a total of 2 patents, Scevola's work focuses on innovative therapeutic solutions that enhance patient care.
Latest Patents
Scevola's latest patents include "Diacetylrhein salts and their therapeutical use in the treatment of arthrosis diseases." This patent describes a therapeutic treatment that involves administering an aqueous solution containing diacetyl rhein salts via the intraarticular route. The solution ranges from 1 to 5 ml and contains between 10 to 50 mg of the active ingredient. The intraarticular administration of diacetyl rhein salts has been shown to exhibit higher pharmacological activity compared to oral administration. Another patent, "Galenic formulations for oral use of rhein derivatives with delayed release," outlines methods for preparing oral pharmaceutical forms that provide delayed release of rhein and its derivatives. The active ingredient is formulated as granules coated with substances such as polyvinylpyrrolidone, shellac, and hydroxypropylmethyl cellulose, which help to resist gastric juices and gradually dissolve in the intestines.
Career Highlights
Mario Ercole Scevola is associated with Proter S.p.A., where he continues to develop innovative pharmaceutical solutions. His work has contributed to advancements in therapeutic treatments, particularly for conditions affecting joint health.
Collaborations
Scevola collaborates with notable colleagues, including Germano Coppi and Vanna Springolo, who contribute to his research and development efforts.
Conclusion
Mario Ercole Scevola's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to improving therapeutic treatments for arthrosis diseases. His innovative approaches continue to influence the industry and enhance patient care.